Avadel Pharmaceuticals plc
AVDL
$14.20
$0.201.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.92M | -26.41M | -48.83M | -72.58M | -106.22M |
| Total Depreciation and Amortization | 3.60M | 2.97M | 2.68M | 2.00M | 1.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 336.00K |
| Total Other Non-Cash Items | 18.64M | 19.14M | 19.56M | 20.34M | 17.51M |
| Change in Net Operating Assets | -13.87M | -21.13M | -20.32M | -32.57M | -27.32M |
| Cash from Operations | 5.45M | -25.44M | -46.91M | -82.81M | -114.15M |
| Capital Expenditure | -181.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.09M | 42.71M | 51.78M | 64.80M | 69.69M |
| Cash from Investing | 23.91M | 42.71M | 51.78M | 64.80M | 69.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -21.17M | -21.17M |
| Issuance of Common Stock | 3.73M | 3.47M | 15.97M | 15.14M | 14.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 30.00M |
| Cash from Financing | 3.73M | 3.47M | 15.97M | -6.02M | 23.26M |
| Foreign Exchange rate Adjustments | 1.47M | -169.00K | -639.00K | 806.00K | 59.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.56M | 20.58M | 20.20M | -23.23M | -21.14M |